Global Bipolar Depression Market Research Report 2021
03 août 2021 05h33 HE
|
Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Bipolar Depression - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This 'Bipolar...
Nexstim Receives an NBS System Upgrade Order from a University Hospital in Finland
16 juil. 2021 02h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 16 July 2021 at 9:00 PM (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received a new NBS System upgrade order from a university...
Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50%
21 juin 2021 03h30 HE
|
Nexstim Oyj
Press Release, Helsinki, June 21, 2021 at 10:30 AM (EEST) Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50% Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland
29 avr. 2021 03h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 29 April 2021 at 10:00 AM (EEST) Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Plc Business and Clinical Update Q1 2021
22 avr. 2021 05h00 HE
|
Nexstim Oyj
Press release, Helsinki, 22.04.2021, 12.00 pm (EEST) Nexstim Plc Business and Clinical Update Q1 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the key highlights of...
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
16 avr. 2021 05h00 HE
|
Nexstim Oyj
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX,...
Psilocybin Mushrooms Use For Mental Health Research By The Recover
12 avr. 2021 03h00 HE
|
The Recover
HUNTINGTON BEACH, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- The Recover, a national news provider for mental health and substance abuse, recently began releasing news about psilocybin and their...
Depression Treatment Therapy Market 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast Report 2021-2028
07 avr. 2021 09h13 HE
|
Fortune Business Insights
Pune, India, April 07, 2021 (GLOBE NEWSWIRE) -- The global ”depression treatment therapy market” size is expected to gain momentum backed by the increasing incidence of suicides and the growing...
Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder
12 mars 2021 03h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 12 March 2021 at 10.00 (EET) Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...
Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital
03 mars 2021 02h00 HE
|
Nexstim Oyj
Company announcement, Inside information, Helsinki, 3 March 2021 at 9.00 am (EET) Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University...